iTonic Holdings Ltd（ITOC）股票分析

$1.645

-0.053 (-3.24%)收盘时

Loading chart…

最高: 1.720
开盘: 1.630
成交量加权均价: 1.67
成交量: 6.05K
市值: —
最低: 1.630
成交额: 10.07K
企业价值/息税折旧摊销前利润（TTM）: 0.00

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

www.ftzy.com.cn/ir

AI 分析 of iTonic Holdings Ltd (ITOC)

卖出

iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.

估值指标

iTonic Holdings Ltd（ITOC）当前预期市盈率为 0.00，5 年平均预期市盈率为。

预期市盈率

5 年均值 P/E

当前P/E

0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA

当前EV/EBITDA

0.00

预期市销率

5 年均值 P/S

当前P/S

0.00

事件时间线

2026-10-02 (ET)

09:30:00

iTonic Shareholders Approve 16-for-1 Share Consolidation

2026-02-06 (ET)

06:10:00

iTonic Holdings Files $200M Mixed Securities Shelf

查看更多事件

资讯

查看更多资讯

ITOC 常见问题 —— 由 Alphio AI 解答

iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.